Elicio Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Elicio Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2020 to Q1 2024.
  • Elicio Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $379K, a 21.5% increase year-over-year.
  • Elicio Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $1.38M, a 24.8% increase from 2022.
  • Elicio Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $1.11M, a 6.19% decline from 2021.
  • Elicio Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $1.18M, a 9.07% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $379K +$67K +21.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $312K -$11K -3.41% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $323K +$56K +21% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $267K -$29K -9.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $296K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.